En violet : Méta-analyse en réseau (MTC) En vert : positif. En rouge : négatif ,
Les Comptes de la Sécurité Sociale -Rapport -Résultats 2013, 2014. ,
Rapport de synthèse. Les comparaisons indirectes : Méthodes et validités, 2009. ,
Indirect Evidence: Indirect Treatment Comparisons in Meta-Analysis. Canadian Agency for Drugs and Technologies in Health, 2009. ,
Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report, Value in Health, vol.17, issue.2, pp.157-73, 2014. ,
DOI : 10.1016/j.jval.2014.01.004
Indirect comparisons of competing interventions, Health Technology Assessment, vol.9, issue.26, 2005. ,
DOI : 10.3310/hta9260
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses, BMJ, vol.326, issue.7387, pp.472-472, 2003. ,
DOI : 10.1136/bmj.326.7387.472
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials, Journal of Clinical Epidemiology, vol.50, issue.6, pp.683-91, 1997. ,
DOI : 10.1016/S0895-4356(97)00049-8
Cochrane handbook for systematic reviews of interventions Wiley Online Library, 2008. ,
What is indirect comparison, 2009. ,
Simultaneous comparison of multiple treatments: combining direct and indirect evidence, BMJ, vol.331, issue.7521, pp.897-900, 2005. ,
DOI : 10.1136/bmj.331.7521.897
Combination of direct and indirect evidence in mixed treatment comparisons, Statistics in Medicine, vol.48, issue.20, pp.3105-3129, 2004. ,
DOI : 10.1002/sim.1875
Pharmacological interventions for non-ulcer dyspepsia, Cochrane Database Syst Rev, p.1960, 2006. ,
Selective Serotonin Reuptake Inhibitors (SSRIs) for Major Depression. Canadian Coordinating Office for Health Technology Assessment, 1997. ,
Network meta-analysis for indirect treatment comparisons, Statistics in Medicine, vol.29, issue.16, pp.2313-2337, 2002. ,
DOI : 10.1002/sim.1201
Evaluation of networks of randomized trials, Statistical Methods in Medical Research, vol.21, issue.11, pp.279-301, 2008. ,
DOI : 10.1177/0962280207080643
Conceptual and Technical Challenges in Network Meta-analysis, Annals of Internal Medicine, vol.159, issue.2, pp.130-137, 2013. ,
DOI : 10.7326/0003-4819-159-2-201307160-00008
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis, The Lancet, vol.369, issue.9557, pp.201-208, 2007. ,
DOI : 10.1016/S0140-6736(07)60108-1
Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy, Annals of Internal Medicine, vol.130, issue.12, pp.995-1004, 1999. ,
DOI : 10.7326/0003-4819-130-12-199906150-00008
A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure, Journal of Clinical Epidemiology, vol.62, issue.12, pp.1279-83, 2009. ,
DOI : 10.1016/j.jclinepi.2008.04.012
Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents, JAMA, vol.289, issue.19, pp.2534-2578, 2003. ,
DOI : 10.1001/jama.289.19.2534
The theory of probability, pp.9-9, 1998. ,
Bayesian Theory, 2009. ,
DOI : 10.1002/9780470316870
Bayesian Approaches to Clinical Trials and Health-Care Evaluation, 2004. ,
DOI : 10.1002/0470092602
Methods for meta- analysis in medical research, 2000. ,
Bayesian approaches to clinical trials and health- care evaluation, 2004. ,
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial, Journal of Clinical Epidemiology, vol.64, issue.2, pp.163-71, 2011. ,
DOI : 10.1016/j.jclinepi.2010.03.016
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, The Lancet, vol.378, issue.9799, pp.1306-1321, 2011. ,
DOI : 10.1016/S0140-6736(11)60873-8
Addressing Reporting Biases, Cochrane Handb Syst Rev Interv Cochrane Book Ser, pp.297-333, 2008. ,
DOI : 10.1002/9780470712184.ch10
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials, Thorax, vol.63, issue.2, pp.122-130, 2008. ,
DOI : 10.1136/thx.2007.082636
Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis, Clinical Epidemiology, vol.3, pp.107-136, 2011. ,
DOI : 10.2147/CLEP.S16235
La méta-régression comme méthodologie de comparaisons indirectes : une réponse aux éxigences contemporaines de l'évaluation du médicament, Paris, vol.11, 2007. ,
How should meta-regression analyses be undertaken and interpreted?, Statistics in Medicine, vol.315, issue.11, pp.1559-73, 2002. ,
DOI : 10.1002/sim.1187
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors, Journal of Clinical Epidemiology, vol.57, issue.7, pp.683-97, 2004. ,
DOI : 10.1016/j.jclinepi.2003.12.001
Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation, Statistics in Medicine, vol.25, issue.15, pp.1861-81, 2009. ,
DOI : 10.1002/sim.3594
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered, Journal of Clinical Epidemiology, vol.62, issue.8, pp.857-64, 2009. ,
DOI : 10.1016/j.jclinepi.2008.10.001
Estimation and adjustment of bias in randomized evidence by using mixed treatment comparison meta-analysis, Journal of the Royal Statistical Society: Series A (Statistics in Society), vol.336, issue.3, pp.613-642, 2010. ,
DOI : 10.1111/j.1467-985X.2010.00639.x
Frequency of Treatment-Effect Modification Affecting Indirect Comparisons, PharmacoEconomics, vol.31, issue.9, pp.723-755, 2010. ,
DOI : 10.2165/11535670-000000000-00000
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials, QJM, vol.104, issue.2, pp.109-133, 2011. ,
DOI : 10.1093/qjmed/hcq165
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head, Statistics in Medicine, vol.273, issue.3, pp.371-87, 2002. ,
DOI : 10.1002/sim.1023
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews, BMJ, vol.338, issue.apr03 1, 2009. ,
DOI : 10.1136/bmj.b1147
Measuring inconsistency in meta-analyses, BMJ, vol.327, issue.7414, pp.557-60, 2003. ,
DOI : 10.1136/bmj.327.7414.557
The Interpretation of Random-Effects Meta-Analysis in Decision Models, Medical Decision Making, vol.25, issue.6, pp.646-54, 2005. ,
DOI : 10.1177/0272989X05282643
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions, Journal of Clinical Epidemiology, vol.61, issue.5, pp.455-63, 2008. ,
DOI : 10.1016/j.jclinepi.2007.06.006
Evidence Synthesis for Decision Making 2, Medical Decision Making, vol.14, issue.5, pp.607-624, 2013. ,
DOI : 10.3310/hta10460
How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis, JAMA, vol.308, issue.12, pp.1246-53, 2012. ,
DOI : 10.1001/2012.jama.11228
Checking consistency in mixed treatment comparison meta-analysis, Statistics in Medicine, vol.172, issue.15, pp.932-976, 2010. ,
DOI : 10.1002/sim.3767
Assessing Evidence Inconsistency in Mixed Treatment Comparisons, Journal of the American Statistical Association, vol.101, issue.474, pp.447-59, 2006. ,
DOI : 10.1198/016214505000001302
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study, BMJ, vol.343, issue.aug16 2, pp.4909-4909, 2011. ,
DOI : 10.1136/bmj.d4909
Analgesic efficacy of paracetamol and its combination with codeine and caffeine in surgical pain-a meta-analysis, Journal of Clinical Pharmacy and Therapeutics, vol.6, issue.Suppl., pp.261-82, 1996. ,
DOI : 10.1111/j.1365-2710.1996.tb01148.x
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database, The International Journal of Neuropsychopharmacology, vol.4, issue.02, pp.113-121, 2001. ,
DOI : 10.1017/S1461145701002322
The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration, Prev Treat, vol.5, 2002. ,
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2, Annals of Internal Medicine, vol.132, issue.9, pp.743-56, 2000. ,
DOI : 10.7326/0003-4819-132-9-200005020-00011
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, The Lancet, vol.373, issue.9665, pp.746-58, 2009. ,
DOI : 10.1016/S0140-6736(09)60046-5
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy, New England Journal of Medicine, vol.358, issue.3, pp.252-60, 2008. ,
DOI : 10.1056/NEJMsa065779
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?, Philosophy, Ethics, and Humanities in Medicine, vol.3, issue.1, p.14, 2008. ,
DOI : 10.1186/1747-5341-3-14
BORROWING STRENGTH FROM EXTERNAL TRIALS IN A META-ANALYSIS, Statistics in Medicine, vol.15, issue.24 ,
DOI : 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0
Ranking antidepressants, The Lancet, vol.373, issue.9677, pp.1759-60, 2009. ,
DOI : 10.1016/S0140-6736(09)60974-0
Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder, Annals of Internal Medicine, vol.155, issue.11, pp.772-85, 2011. ,
DOI : 10.7326/0003-4819-155-11-201112060-00009
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1, Value in Health, vol.14, issue.4, pp.417-445, 2011. ,
DOI : 10.1016/j.jval.2011.04.002
Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments, JNCI Journal of the National Cancer Institute, vol.98, issue.22, pp.1655-63, 2006. ,
DOI : 10.1093/jnci/djj443
Assessing the potential for outcome reporting bias in a review: a tutorial, Trials, vol.129, issue.6, p.52, 2010. ,
DOI : 10.1016/S0022-3476(96)70023-9
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, Ann Intern Med, vol.151, p.65, 2009. ,
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis, The Lancet, vol.382, issue.9896, pp.951-62, 2013. ,
DOI : 10.1016/S0140-6736(13)60733-3
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, vol.343, issue.oct18 2, 2011. ,
DOI : 10.1136/bmj.d5928
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Controlled Clinical Trials, vol.17, issue.1, pp.1-12, 1996. ,
DOI : 10.1016/0197-2456(95)00134-4
Exploring the Geometry of Treatment Networks, Annals of Internal Medicine, vol.148, issue.7, pp.544-53, 2008. ,
DOI : 10.7326/0003-4819-148-7-200804010-00011
Bayesian methods in health technology assessment: a review, Core Research, vol.21, p.38, 2000. ,
Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study, Journal of Clinical Epidemiology, vol.58, issue.3, pp.261-269, 2005. ,
DOI : 10.1016/j.jclinepi.2004.08.010
Developing critical thinking about reporting of Bayesian analyses, J Stat Educ, vol.20, p.1, 2012. ,
Drug Class Review: Second Generation Antidepressants: Final Report Update 4, p.21089243, 2008. ,
Multiple treatment meta-analysis in rheumatoid arthritis can provide weak inferences due to methodological approaches, 2012. ,
ESSAIS cliniques ??? Th??orie, pratique et critique, Acta Endoscopica, vol.36, issue.3, pp.375-375, 2006. ,
DOI : 10.1007/BF03006053
Intégration de l'évaluation médico-économique des médicaments en France au sein de la HAS : impact sur l'accès et le maintien des médicaments sur le marché français, 2014. ,
Le rôle de la Commission de la transparence de la HAS dans la pertinence de l'admission au remboursement des médicaments par l'Assurance maladie. Regards Numéro 44, 2013. ,
relative au renforcement de la sécurité sanitaire du médicament et des produits de santé, 2011. ,
The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis, European Urology, vol.54, issue.3, pp.543-62, 2008. ,
DOI : 10.1016/j.eururo.2008.06.047
The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis, European Urology, vol.48, issue.1, pp.5-26, 2005. ,
DOI : 10.1016/j.eururo.2005.02.024
Dopamine agonists for the treatment of restless legs syndrome, Cochrane Database Syst Rev, vol.7, issue.2, p.6009, 2011. ,
DOI : 10.1002/14651858.CD006009.pub2
Efficacy and safety of dopamine agonists in restless legs syndrome, Sleep Medicine, vol.13, issue.3, pp.228-264, 2012. ,
DOI : 10.1016/j.sleep.2011.09.013
Méthodes d'évaluation économique des programmes de santé, 1998. ,
Evaluation médico-économique en santé, Rapport IGAS ,
Décision n°2013.0111/DC/SEESP du 18 septembre 2013 du collège de la Haute Autorité de santé relatif à l'impact significatif sur les dépenses de l'assurance maladie déclenchant l'évaluation médico-économique des produits revendiquant une ASMR ou une ASA de niveaux I, II ou III ,
Choix méthodologiques pour l'évaluation économique à la HAS, 2011. ,
Valeurs de références pour l'évaluation économique en santé Revue de la littérature, 2014. ,
La Ceesp favorable à plusieurs évolutions de l'évaluation médicoéconomique des produits de santé, 2014. ,
Dépistage de l'infection par le VIH en France Stratégies et dispositifs de dépistage, 2009. ,
Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care, BMJ, vol.328, issue.7434, p.254, 2004. ,
DOI : 10.1136/bmj.37956.664236.EE
Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies, Annual Review of Public Health, vol.23, issue.1, pp.377-401, 2002. ,
DOI : 10.1146/annurev.publhealth.23.100901.140534
A Comparison of National Guidelines for Network Meta-Analysis, Value in Health, vol.17, issue.5, pp.642-54, 2014. ,
DOI : 10.1016/j.jval.2014.06.001
Methodological guideline for REA of pharmaceuticals: Direct and indirect comparison, 2013. ,
Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers, BMC Medicine, vol.31, issue.1, p.159, 2013. ,
DOI : 10.1002/sim.5442
Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2, Value in Health, vol.14, issue.4, pp.429-466, 2011. ,
DOI : 10.1016/j.jval.2011.01.011